Companion Diagnostic Global Key Vendors, Manufacturers, Suppliers and Analysis Market Report 2023

Summary:
Wiseguyreports.Com added “Companion Diagnostic Devices Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012 to 2016 and Forecast 2017 to 2023” To Its Research Database.
Scope of Report:
Global Companion Diagnostic Devices Market 
Companion diagnostics are medical devices, often an in-vitro device and provides the information that essential for safe and effective use of the corresponding drug or biotechnology product. Companion diagnostics are often developed along with drugs to aid in selecting or excluding the patient groups for the treatment with particular drug on basis of their biological characters. Companion diagnostics are developed based on biomarkers technology to predict response or severe toxicity of the drugs or biotechnological compounds. Companion diagnostics are majorly used in oncology area.
Some of the factors like improved efficacy and safety profiles of drugs, Accelerated drug regulatory approvals, reduced healthcare expenditure and drug development costs, increasing partnerships between market players, government organizations and other research firms over the use of co diagnostics, emergence of new pharmaceuticals and diagnostics are driving the growth of the global companion diagnostics market. However, due to the regulatory uncertainty, complex clinical trial procedures and intellectual property issues in certain areas are the few issues which are restraining the growth of the global companion diagnostics devices market.
Global companion diagnostic devices are segmented on the basis of application, technology, end user and geographical region.
Based on the application, global companion diagnostic devices are segmented as:Breast Cancer
Colorectal Cancer
Lung Cancer
Urology
Melanoma
Gastric Cancer
Others
Based on the technology, global companion diagnostic devices are segmented as:Immunohistochemistry
Molecular Diagnostics
In-situ Hybridization
FISH
CISH
Real-Time PCR
Gene Sequencing
Based on the end-user, global companion diagnostic devices are segmented as:Hospitals
Diagnostic Centres
Others
The global companion diagnostic devices market is highly fragmented due to the presence of several established large and small suppliers. The competition in the market will intensify during the forecast period as vendors adopt strategies like M&A to develop new technologies. Product approval and launch will also help to increase the volume of available diagnostic devices in the market. In addition, the vendors also work on differentiating their products based on quality, the accuracy of results, and other value added services as it will help them to gain a competitive edge over their peers.
Geographically, companion diagnostic devices market is segmented into five regions: North America, Europe, Latin America, Asia-Pacific and Middle East & Africa. North America expected to be major market for companion diagnostics owing to growth innovative technologies in biomarkers, increase in R&D investment in the region. Asia-Pacific and Europe are expected to grow at a significant rate owing to large patent and consumer base, increasing government initiatives developing healthcare infrastructure, and growing disposable income.
Some of the players in companion diagnostic devices market are F. Hoffmann-La Roche Ltd.(Switzerland), Qiagen Ltd. (Germany), ARUP Laboratories (U.S.), Abbott Laboratories (U.S.), Biogenex Laboratories, Inc. (U.S), Thermo Fisher Scientific (U.S), Ventana Medical Systems Inc. (U.S), Myriad Genetics Inc. (U.S), and Danaher (U.S) and others.
In June 2015, Ventana Medical Systems, Inc. (RocheGroup) has received USFDA approval for its ventana alk cdx assay, companion diagnostic to aid in the identification of patients for, xalkori (crizotinib) (Pfizer’s FDA approved targeted therapy)
In July 2014, AstraZeneca collaborated with Roche to develop a plasma-based companion diagnostic test to support azd9291, for non-small-cell lung cancer
In 2014, Ventana Medical Systems, Inc., collaborated with ImmunoGen, Inc. to develop biomarker assays and a companion diagnostic immunohistochemistry test (IHC) for one ImmunoGen’s product candidates
Major Key Points in Table of Content:
  1. Executive Summary 
  2. Global Companion Diagnostic Devices Market Introduction 
  3. Global Companion Diagnostic Devices Market Dynamics3.1. Drivers
    3.2. Restraints
    3.3. Opportunities/Unmet Needs of the Market
  4. Global Companion Diagnostic Devices Market Analysis, 2012 – 2016 and Forecast, 2017 – 20234.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
    4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
    4.3. Market Opportunity Analysis
  5. Global Companion Diagnostic Devices Market, By Technology, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)5.1. Immunohistochemistry
    5.2. Molecular Diagnostics
    5.3. In-situ Hybridization
  6. Global Companion Diagnostic Devices Market, By Application, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)6.1. Breast Cancer
    6.2. Colorectal Cancer
    6.3. Lung Cancer
  7. Global Companion Diagnostic Devices Market, By End User, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
    7.1. Hospitals
    7.2. Diagnostic Centers
    7.3. Others

Continuous…

Contact Us:
NORAH TRENT
Partner Relations & Marketing Manager
sales@wiseguyreports.com
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)

Comments

Popular posts from this blog

Report on Angola Telecoms, Mobile and Broadband Market Status, Market Size by Players, Regions, Type, Application and Forecast to 2021

Telecoms, Mobile and Broadband 2019-2023 Laos Market Survey Industry Key Players – Lao Telecom, Thaicom, ETL, Unitel, Lao Asia Telecom, Star Telecom, Viettel

Guinea Telecoms, Mobile and Broadband Industry 2018 Analysis and Forecast Market Research Report